MoneyShow presents top investment ideas for 2026 from leading advisors. Part 1 includes Ceragon Networks, Celldex, ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

FDA accelerated path and Risto-cel 2026 catalysts, strong cash runway to 2029—read now. Click for more on BEAM.

Explore why GSI Technology (GSIT) earns a Buy: edge AI APU breakthrough, SRAM rebound, debt-free strength, and key risks.

Recent news indicates the DoJ is opening an investigation into the Fed Chair. This introduces a new and material challenge ...

Main Street Capital (MAIN) offers resilient NAV growth and well-covered 5–7% dividends, but a premium valuation limits upside ...

Nebius Group N.V. stock may have put in a bottom. Click for this updated look at NBIS stock and why I remain very bullish ...

Thiel was also one of the founders of Palantir ( PLTR ). Leveraging some of the early fraud detection systems of PayPal, ...

Last year, President Donald Trump approved the sale of some advanced AI chips, including Nvidia's H200 GPUs, to China. The ...

PepsiCo’s M&A missteps hurt long-term returns—read why dividend investors should rethink PEP stock despite a 4% yield.

Apple Inc. to add Google Gemini AI to Siri—could spur iPhone upgrades, but $1B/year costs may hit profits. Click for this ...

The AI Narrative that has powered the rally in the markets for the past three years has equities in extreme valuation ...